Related Experiment Video
Updated: Aug 20, 2026
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)
Published on: December 19, 2019
Crucial role of phospholipase Cepsilon in chemical carcinogen-induced skin tumor development
Yunfeng Bai1, Hironori Edamatsu, Sakan Maeda
1Division of Molecular Biology, Department of Molecular and Cellular Biology and Division of Molecular Pathology, Kobe University Graduate School of Medicine, Kobe, Japan.
Abstract:
Mutational activation of the ras proto-oncogenes is frequently found in skin cancers. However, the nature of downstream signaling pathways from Ras involved in skin carcinogenesis remains poorly understood. Recently, we and others identified phospholipase C (PLC) epsilon as an effector of Ras. Here we have examined the role of PLCepsilon in de novo skin chemical carcinogenesis by using mice whose PLCepsilon is genetically inactivated. PLCepsilon(-/-) mice exhibit delayed onset and markedly reduced incidence of skin squamous tumors induced by initiation with 7,12-dimethylbenz(a)anthracene followed by promotion with 12-O-tetradecanoylphorbol-13-acetate (TPA). Furthermore, the papillomas formed in PLCepsilon(-/-) mice fail to undergo malignant progression into carcinomas, in contrast to a malignant conversion rate of approximately 20% observed with papillomas in PLCepsilon(+/+) mice. In all of the tumors analyzed, the Ha-ras gene is mutationally activated irrespective of the PLCepsilon background. The skin of PLCepsilon(-/-) mice fails to exhibit basal layer cell proliferation and epidermal hyperplasia in response to TPA treatment. These results indicate a crucial role of PLCepsilon in ras oncogene-induced de novo carcinogenesis and downstream signaling from TPA, introducing PLCepsilon as a candidate molecular target for the development of anticancer drugs.
Insights
Phospholipase C (PLC) epsilon plays a crucial role in skin cancer development. Inactivating PLC epsilon in mice significantly reduced tumor formation and progression, highlighting it as a potential anticancer drug target.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- Ras proto-oncogenes are frequently mutated in skin cancers.
- Downstream signaling pathways from Ras in skin carcinogenesis are not fully understood.
- Phospholipase C (PLC) epsilon has been identified as a Ras effector.
Purpose of the Study:
- To investigate the role of PLC epsilon in de novo skin chemical carcinogenesis.
- To determine the impact of PLC epsilon genetic inactivation on tumor development and progression.
- To explore PLC epsilon as a potential molecular target for anticancer drug development.
Main Methods:
- Utilized genetically modified mice with inactivated PLC epsilon (PLCepsilon(-/-)).
- Induced skin carcinogenesis using 7,12-dimethylbenz(a)anthracene (initiation) and 12-O-tetradecanoylphorbol-13-acetate (TPA) (promotion).
- Analyzed tumor incidence, progression, Ha-ras gene mutations, and epidermal responses to TPA.
Main Results:
- PLCepsilon(-/-) mice showed delayed onset and reduced incidence of skin squamous tumors.
- Papillomas in PLCepsilon(-/-) mice failed to progress to carcinomas.
- Ha-ras gene was mutationally activated in all analyzed tumors, regardless of PLC epsilon status.
- PLCepsilon(-/-) skin did not exhibit basal layer cell proliferation or epidermal hyperplasia in response to TPA.
Conclusions:
- PLC epsilon is essential for Ras oncogene-induced skin carcinogenesis.
- PLC epsilon plays a critical role in downstream signaling from TPA.
- PLC epsilon represents a promising molecular target for anticancer therapies in skin cancer.
Related Concept Videos
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
IP3/DAG Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade
Mutagenicity and Carcinogenicity
Abnormal Proliferation
